CHAT and Alzheimer disease: In two independent treatment studies in AD patients (one with encapsulated NGF-releasing cells and the other with a ChEI), we showed that CSF ChAT levels increased in response to the treatment and that the increase was positively correlated with measures of cognition (Karami et al., 2015, 2019).